Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Ketamine Treatment
Recent news which mentions Ketamine Treatment
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
August 26, 2024
Tickers
NEWS
NRXP
Tags
Ketamine Treatment
Benzinga
Psychedelics
From
Benzinga
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
January 08, 2024
Tickers
NEWS
OPTHF
PMBHF
Tags
PMBHF
Psychedelic/Assisted Therapies
Psychedelics Reform
From
Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
SILO
GHRS
Penny Stocks
From
Benzinga
Super Model Chrissy Teigen Talks About Ketamine Therapy Session, Says She Saw 'Space & Time'
December 04, 2023
Tags
Ketamine Treatment
Chrissy Teigen
Entertainment
From
Benzinga
Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans
November 27, 2023
Tickers
DOD
SEEL
Tags
Psychedelics
Benzinga
Dr/ Raj Mehra
From
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Tickers
JNJ
Tags
Markets
Market News
Cannabis
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
MYCOF
DMTTF
Markets
From
Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
September 27, 2023
Tickers
PHRRF
Tags
Abbreviated New Drug Application
Markets
Market News
From
Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
September 06, 2023
Tickers
PHRRF
Tags
Drug Delivery Technologies
Abbreviated New Drug Application
Market News
From
Benzinga
Breaking Ground In Prevention & Relief Of Anxiety & PTSD: Silo Pharma' Nasal Formulation For Ketamine-Based Treatment
August 08, 2023
Tickers
SILO
Tags
Global
Drug Delivery Technologies
Markets
From
Benzinga
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
August 01, 2023
Tickers
AWKNF
Tags
AWKNF
Psychedelics
Benzinga
From
Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
June 27, 2023
Tickers
FTHWF
PHRRF
Tags
Ketamine Treatment
Benzinga
Psychedelics
From
Benzinga
Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making
June 13, 2023
Tickers
SILO
TRYPF
Tags
Ketamine Treatment
News
TRYPF
From
Benzinga
Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History
May 16, 2023
Tickers
SEEL
Tags
SEEL
Markets
Cannabis
From
Benzinga
Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?
May 10, 2023
Tickers
SILO
Tags
Alzheimer’s
News
Stress/Induced Disorders
From
Benzinga
Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations
April 14, 2023
Tickers
ATAI
Tags
News
ATAI
Penny Stocks
From
Benzinga
Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval
March 30, 2023
Tickers
PHRRF
Tags
PHRRF
Legal
FDA
From
Benzinga
Silo Pharma To Patent Novel Ketamine-Based Treatment For Chronic Condition
March 27, 2023
Tickers
SILO
Tags
Legal
Management
Ketamine Treatment
From
Benzinga
Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms
March 22, 2023
Tickers
BWVI
Tags
News
Penny Stocks
Cannabis
From
Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
March 16, 2023
Tickers
BRAXF
IWINF
Tags
Ketamine Treatment
Psychedelics
Benzinga
From
Benzinga
Awakn's First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics
February 22, 2023
Tickers
AWKNF
Tags
Global
Contracts
Cannabis
From
Benzinga
Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials
February 16, 2023
Tickers
BWVI
Tags
Management
BWVI
Market News
From
Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
Tickers
AWKNF
HUGE
Tags
Market News
Cannabis
Markets
From
Benzinga
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy
February 07, 2023
Tickers
SEEL
Tags
Psychedelics/Assisted Therapy
Cannabis
Market News
From
Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
February 03, 2023
Tickers
PHRRF
RVVTF
Tags
FDA Approval
MDMA Therapy
FDA
From
Benzinga
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
January 31, 2023
Tickers
CMND
Tags
Ketamine Treatment
Psychedelics
Benzinga
From
Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
December 16, 2022
Tickers
EHVVF
Tags
EHVVF
Psychedelics
Benzinga
From
Benzinga
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
December 15, 2022
Tickers
PHRRF
Tags
Market News
Cannabis
Markets
From
Benzinga
Psychedelic-Assisted Therapies: Upcoming Moves In Montana, Colorado And Ontario
November 22, 2022
Tags
Ketamine Treatment
News
Psilocybin/Assisted Therapy
From
Benzinga
This New Psychedelic Therapy Program Will Accompany Patients In Their Healing Journey For A Whole Year
November 15, 2022
Tags
Benzinga
Psychedelics
Ketamine Treatment
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.